Drugs / SPD602
SPD602
Trials 7
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 12 trials | ||||||
| Phase 1 | NCT02065401 | Feb → Mar 2014 | — | Shire | Withdrawn | No outcome recorded |
| Phase 1 | NCT01039636 | Nov 2009 → Dec 2010 | beta thalassemia, disorder of iron metabolism and transport | FerroKin BioSciences, Inc. | Completed | No outcome recorded |
| Phase 25 trials · 1 missed | ||||||
| Phase 2 | NCT01927913 | Nov 2014 → Oct 2015 | beta thalassemia, disorder of iron metabolism and transport, hemosiderosis | Shire | Withdrawn | No outcome recorded |
| Phase 2 | NCT01604941 | Sep 2012 → Apr 2014 | disorder of iron metabolism and transport | Shire | Terminated | No outcome recorded |
| Phase 2 | NCT01671111 | Aug 2012 → Apr 2014 | hemosiderosis | Shire | Terminated | Missed primary |
| Phase 2 | NCT01363908 | Aug 2011 → May 2014 | beta thalassemia, disorder of iron metabolism and transport | Shire | Terminated | No outcome recorded |
| Phase 2 | NCT01186419 | Aug 2010 → Jan 2013 | beta thalassemia, disorder of iron metabolism and transport | Shire | Completed | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 7 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SPD602 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01186419 ↗ |
| Known as | Deferitazole | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02065401 ↗ |
| Known as | FBS0701 | “Study for Transfusionally Iron Overloaded Children, Adolescents and Adults Using FBS0701 (SSP-004184)” NCT01671111 ↗ |
| Known as | SSP-004184 | “Study for Transfusionally Iron Overloaded Children, Adolescents and Adults Using FBS0701 (SSP-004184)” NCT01671111 ↗1“SPD602 (FBS0701, SSP-004184)” NCT01186419 ↗ |
| Known as | SSP-004184AQ | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01671111 ↗ |
| Route | Oral | “FBS0701 is a new, oral iron chelator” NCT01039636 ↗ |